Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa

BACKGROUND: Colon cancer incidence is rising in low‐ and middle‐income countries (LMICs), where resource limitations and cost often dictate treatment decisions. In this study, we evaluate the cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer treatment in S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Sarah Xinhui, Pumpalova, Yoanna, Rogers, Alexandra M., Bhatt, Kishan, Herbst, Candice‐lee, Ruff, Paul, Neugut, Alfred I., Hur, Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417185/
https://www.ncbi.nlm.nih.gov/pubmed/37318753
http://dx.doi.org/10.1002/cam4.6199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417185/
https://www.ncbi.nlm.nih.gov/pubmed/37318753
http://dx.doi.org/10.1002/cam4.6199

Ejemplares similares